Navigation Links
BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
Date:10/27/2008

trial in hospitalized influenza was recently completed and BioCryst's partner, Shionogi & Co., Ltd. is preparing for a pivotal Phase 3 trial of peramivir in outpatient influenza.

About BioCryst

BioCryst is an integrated biopharmaceutical company utilizing crystallography and structure-based drug design to develop a deep pipeline of novel therapeutics targeting major illnesses. BioCryst is currently advancing investigational new drugs discovered in-house in late-stage clinical trials for influenza and lymphoma. In addition, the Company has a pre-clinical portfolio of novel compounds, directed against infectious, cardiovascular, and autoimmune disease targets, to create long-term sustainable value. The Company's strategic alliances with the U.S. Department of Health and Human Services, Shionogi & Co., Ltd., Green Cross Corporation and Mundipharma International Holdings Ltd. validate its scientific foundation and the utility of its product candidates. For more information, please visit the Company's website at http://www.biocryst.com.

Forward-looking Statements

This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include that our belief that many subjects in the Phase II clinical trials of peramivir did not receiv
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
2. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
3. BioCryst to Present at UBS 2007 Global Life Sciences Conference
4. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
6. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
7. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
8. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
9. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
10. BioCryst to Present at UBS 2008 Global Life Sciences Conference
11. BioCryst to Present at the JMP Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014 In preparation for ... -based cybersecurity company focused on authentication and SSO ... support the ability to generate a OTP through the ... a pioneer of user-based RFID authentication, 2FA,s solutions have ... access, for many years. RFID authentication is broadly deployed ...
(Date:9/15/2014)...   Global Science & Technology, Inc. (GST) ... services for satellite and weather systems, was awarded ... (OASIS) from the General Services Administration (GSA) Federal ... the government best-value solutions for complex professional service ... Pool 4. The OASIS SB award has an ...
(Date:9/15/2014)... when a patient has sepsis, a life-threatening condition in ... -- often too fast for antibiotics to help. A ... by a team at Harvard,s Wyss Institute for Biologically ... sepsis. , "Even with the best current treatments, ... least 30 percent of the time," said Mike Super, ...
(Date:9/15/2014)... BOISE, Idaho , Sept. 15, 2014  iVinci ... and only comprehensive Patient Revenue Management system, branded as ... The company also announced the launch of a new ... Portal that provides an easy and convenient way for ... plans for balances owed by them and their families. ...
Breaking Biology Technology:2FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 2Global Science & Technology, Inc. Awarded GSA OASIS Small Business Contract 3Blood-cleansing biospleen device developed for sepsis therapy 2Blood-cleansing biospleen device developed for sepsis therapy 3Blood-cleansing biospleen device developed for sepsis therapy 4iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3
... Almost everybody knows the University of Wisconsin-Madison ... But a new study has produced figures to back ... in the University Research Park , located three ... university research. And the concentration of these innovative firms, ...
... has heard of identity theft (IDT), yet unless you have ... high risk. An alarming figure is that over half of ... place of business, employer, or other entity (not-for-profit or local, ... are required under one or more federal and state laws ...
... Madison-based National Stem Cell Bank has announced it ... of California-San Francisco , giving it 13 of the 21 ... Donley, executive director of the WiCell Research Institute , ... optimistic that it eventually will have all 21 federally approved ...
Cached Biology Technology:Impact of research park firms pegged at $680M 2Identity theft: The business time bomb 2Identity theft: The business time bomb 3Identity theft: The business time bomb 4Nation's only stem cell bank will receive UC-San Francisco cell line 2
(Date:9/16/2014)... can take up residence in and on the human ... symptom, according to new research at Washington University School ... healthy individuals carry about five types of viruses on ... Central Biology . The study is the first comprehensive ... people. , The research was conducted as part ...
(Date:9/16/2014)... interaction between viruses, bacteria, and their environment is ... collaboration between Matthew Sullivan, associate professor in the ... Biology and Steven Hallam from the University of ... are drivers of nutrient and energy cycles that ... is changing, so are the environments these bacteria ...
(Date:9/16/2014)... 2014 Schizophrenia is associated with increased rates and ... research suggests that the relationship between schizophrenia and smoking ... use nicotine to self-medicate symptoms and cognitive impairment associated ... the current issue of Biological Psychiatry , sheds ... level of nicotine receptors in the brain was lower ...
Breaking Biology News(10 mins):Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3New research decodes virus-host interactions in ocean dead zones 2New research decodes virus-host interactions in ocean dead zones 3Smoking and schizophrenia linked by alterations in brain nicotine signals 2
... For two weeks in March, some of the greatest names ... take part in public discussions on how fundamental discoveries in ... understanding of life and civilization -- and our grasp of ... & Life of Beginnings," this one-of-a-kind program was organized by ...
... Global climate rapidly shifted from a relatively ice-free world ... 34 million years ago. What happened? What changed? ... a new perspective on the nature of changing climatic ... and has important implications for predicting future climate changes. ...
... CLEMSON, SCIn areas of the U.S. where golfers can ... traffic, and frost can wreak havoc on healthy greens ... Creeping bentgrass ( Agrostis stolonifera var. palustris Huds. ), ... is often preferred because of its year-round green color, ...
Cached Biology News:World's top minds to celebrate 'the birth and life of beginnings' 2World's top minds to celebrate 'the birth and life of beginnings' 3World's top minds to celebrate 'the birth and life of beginnings' 4CO2 drop and global cooling caused Antarctic glacier to form 2This grass is still greener 2
... NeuroLog System is a compact, versatile & modular ... of purposes including: Intracellular, Extracellular, Transducer & ... The NeuroLog Case & Power Supply unit (NL900D) ... Modules are not only powered by this unit, ...
Rat Epidermal Keratinocytes (REK) (>500,000 cells)...
... Precision Model 410 is a four-channel general purpose ... small signals from sources which may have a ... channel consists of a high gain/low noise amplifier, ... and an output offset control. A control knob ...
Porcine Coronary Artery Endothelial Cells (PCAEC) (>500,000 cells)...
Biology Products: